Skip to main content
Clinical Trials/NL-OMON39619
NL-OMON39619CompletedNot Applicable

Surgical and aesthetic outcome, quality of life, and cost-effectiveness of keloid treatment - Keloid

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites176 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
176

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Keloid patients, 18-75 yr old, full mental competence, sufficient knowledge of Dutch or English language, keloid suitable for primairy closure after excision, minimum keloid size of 1x1cm.

Exclusion Criteria

  • Hypertrofic scars. Keloids less than 1 year existent, burn scars, pregnancy, previous radiotherapy which prohibits additional rediotherapy (only for the group of recurrent keloids), hypersensitivity for lidocaine, adrenaline, triamcinolone. Chronic use (>1 month) of systemic corticosteroids, or immunosuppressive medication (e.g. TNF alfa inhibitors). Use of systemic chemotherapy. Severe morbidity with a life expectancy of less than one year.

Investigators

Similar Trials

Surgical and aesthetic outcome, quality of... | Clinical Trial